Web-based program to identify individuals at risk for Alzheimer's disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Alzheimer Prevention Trials (APT) Webstudy aims to enhance enrollment in Alzheimer's disease clinical trials by identifying individuals at higher risk for developing dementia. Participants will register online, complete cognitive tests, and provide demographic information. They will return quarterly for follow-up assessments, and based on their risk scores, some may be invited for in-person evaluations at clinical trial sites. This approach combines web-based assessments with biomarker testing to refine the selection of high-risk individuals for further studies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* male or female at least 50 years of age
* no evidence of dementia
* willing to participate in remote longitudinal cognitive testing and possible referral for biomarker assessment based on risk

Exclusion Criteria:

* N/A. Anyone can register for the APT Webstudy, however, only individuals identified using the risk algorithm will be referred for in-person biomarker assessments.

Where it's running

• Https://Www.Aptwebstudy.Org
  San Diego, California, United States Recruiting

Study contacts

• Principal investigator: Paul Aisen, MD — USC Atri
• Study coordinator: APT Webstudy Team
• Email: info@aptwebstudy.org
• Phone: 858-877-3135

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Blood biomarker cohort for memory disorders in older adults

  This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.

  Recruiting Yonsei University · Seoul, Seodamun-gu · NCT07880275

• Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns

  This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.

  Recruiting University of Cambridge · Cambridge, CB2 · NCT07786116

• Norms for a Voice-Based Digital Cognitive Test Across Ages

  This study tests a voice-enabled digital cognitive test to establish normal scores for adults aged 18–100.

  Recruiting The Neurology Center of Southern California · Carlsbad, California · NCT07763392

• Lived Experience Narratives in Dementia

  This project tests a digital Online LEND Intervention that shares dementia patients’ and caregivers’ lived experiences to see if it helps wellbeing and connection.

  Recruiting at 2 sites University of Nottingham · Nottingham, England and 1 other locations · NCT07757178

• Blood tests using plasma biomarkers to diagnose and track Alzheimer’s disease

  A large, year-long study in Milan is testing whether blood markers can help diagnose Alzheimer’s and predict how it will progress in people with memory concerns.

  Recruiting IRCCS San Raffaele · Milan, Milano · NCT07717567

• Far-Infrared Therapy for Alzheimer’s Disease Dementia

  This trial tests whether a far-infrared radiator can help people with Alzheimer's-related dementia who are on stable dementia medications.

  Recruiting National Defense Medical Center, Taiwan · Taipei · NCT07672171

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.